Rapid modulation of TRH and TRH-like peptide release in rat brain, pancreas, and testis by a GSK-3β inhibitor

Peptides

Volumn 31, Issue 6, 2010, Pages 1083-1093

  Pekary, Albert Eugene ^a,b   Stevens, Schetema A ^a   Blood, James D ^a   Sattin, Albert ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GSK 3 ; HPLC; Limbic system; Radioimmunoassay; Testis; Thyrotropin releasing hormone

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; PROTIRELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DRUG SPECIFICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE RELEASE; IC 50; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; TESTIS;

ANIMALS; BRAIN; CEREBELLUM; CORTICOSTERONE; GLYCOGEN SYNTHASE KINASE 3; MALE; OLIGOPEPTIDES; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; TESTIS; THIAZOLES; THYROTROPIN-RELEASING HORMONE; TIME FACTORS; UREA;

RATTUS;

EID: 77952108799     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.020     Document Type: Article

References (63)

1. Amir S. Aging blocks the thermoregulatory action of thyrotropin-releasing hormone in anaesthetized rats. Brain Res 440 (1988) 181-184
2. Bacova Z., Najvirtova M., Krizanova O., Hudecova S., Zorad S., Strbak V., et al. Effect of neonatal streptozotocin and thyrotropin-releasing hormone treatments on insulin secretion in adult rats. Gen Physiol Biophys 24 (2005) 181-197
3. Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., and Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368 (2004) 123-126
4. Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett 376 (2005) 51-55
5. Bhat R.V., Budd Haeberlein S.L., and Avila J. Glycogen synthase kinase: a drug target for CNS therapies. J Neurochem 89 (2004) 1212-1317
6. Bhat R.V., Xue Y., Berg S., Hellberg S., Ormo M., Nilsson Y., et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem 278 (2003) 45937-45945
7. Brady S.T. A kinesin medley: biochemical and functional heterogeneity. Trends Cell Biol 5 (1995) 159-164
8. Chin P.C., Majadzadeh N., and D'Mello S.R. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res Mol Brain Res 137 (2005) 193-201
9. Cyr J.L., Pfister K.K., Bloom G.S., Slaughter C.A., and Brady S.T. Molecular genetics of kinesin light chains: generation of isoforms by alternative splicing. Proc Natl Acad Sci USA 88 (1991) 10114-10118
10. Dai F., Yu L., He H., Chen Y., Yu J., Yang Y., et al. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3β (GSK-3β) at serine-9 through direct interaction. Biochem Biophys Res Commun 293 (2002) 1191-1196
11. Du J., Wei Y., Liu L., Khairova R., Wang Y., Blumenthal R., et al. GSK-3 kinase modulates AMPA receptor trafficking via kinesin cargo system: molecular mechanism for mood stabilizer?. Biol Psychiat 65 (2009) 16S Abst. #52
12. Frame S., and Cohen P. GSK3 takes center stage more than 20 years after its discovery. Biochem J 359 Pt. 1 (2001) 1-16
13. Gerendai I., Sziebert P., Gorcs T., Csaba Z., and Csernus V. Effect of intratesticular administration of TRH or anti-TRH antiserum on function of rat testis. Life Sci 67 (2000) 269-281
14. Gould T.D., Einat H., Bhat R., and Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7 (2004) 387
15. Gould T.D., Picchini A.M., Einat H., and Manji H.K. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr Drug Targets 7 (2006) 1399-1409
16. Hinkle P.M., Pekary A.E., Senanayake S., and Sattin A. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides. Brain Res 935 (2002) 59-64
17. Inanami O., Ohno K., and Sato A. Responses of regional cerebral blood flow to intravenous administration of thyrotropin releasing hormone in aged rats. Neurosci Lett 143 (1992) 151-154
18. Jackson I.M., and Luo L.G. Antidepressants inhibit glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons. J Invest Med 46 (1998) 470-474
19. Johansson O., and Hokfelt T. Thyrotropin releasing hormone, somatostatin, and enkephalin: distribution studies using immunohistochemical techniques. J Histochem Cytochem 28 (1980) 364-366
20. Johansson O., Hokfelt T., Jeffcoate S.L., White N., and Sternberger L.A. Ultrastructural localization of TRH-like immunoreactivity. Exp Brain Res 38 (1980) 1-10
21. Kelly S., Zhao H., Sun G.H., Cheng D., Qiao Y., Luo J., et al. Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol 188 (2004) 378-386
22. Khodjakov A., Lizunova E.M., Minin A.A., Koonce M.P., and Gyoeva F.K. A specific light chain of kinesin associates with mitochondria in cultured cells. Mol Biol Cell 9 (1998) 333-343
23. 2 (EEP). Peptides 22 (2001) 2091-2097
24. Koenig M.L., Yourick D.L., and Meyerhoff J.L. Thyrotropin-releasing hormone (TRH) attenuates glutamate-stimulated increases in calcium in primary neuronal cultures. Brain Res 730 (1996) 143-149
25. Kulkarni R.N., Wang Z.L., Akinsanya K.O., Bennet W.M., Wang R.M., Smith D.M., et al. Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Endocrinology 136 (1995) 5155-5164
26. Liberman Z., and Eldar-Finkelman H. Serine332 phosphorylation of insulin receptor substrate-1 byglycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 280 (2005) 4422-4428
27. Lipina C., Huang X., Finlay D., McManus E.J., Alessi D.R., and Sutherland C. Analysis of hepatic gene transcription in mice expressing insulin-insensitive GSK3. Biochem J 392 (2005) 633-639
28. Lloyd R.L., Pekary A.E., Sattin A., and Amundson T. Antidepressant effects of thyrotropin-releasing hormone analogues using a rodent model of depression. Pharmacol Biochem Behav 70 (2001) 15-22
29. Luo L., and Stopa E.G. Thyrotropin releasing hormone inhibits tau phosphorylation by dual signaling pathways in hippocampal neurons. J Alzheimers Dis 6 (2004) 527-536
30. MacAulay K., Blair A.S., Hajduch E., Terashima T., Baba O., Sutherland C., et al. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells. J Biol Chem 280 (2005) 9509-9518
31. Montagne J.J., Ladram A., Grouselle D., Nicolas P., and Bulant M. Identification and cellular localization of thyrotropin-releasing hormone-related peptides in rat testis. Endocrinology 137 (1996) 185-191
32. Morfini G., Szebenyi G., Brown H., Pat H.C., Pigino G., DeBoer S., et al. A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J 23 (2004) 2235-2245
33. Nishimoto T., Kihara T., Akaike A., Niidome T., and Sugimoto H. AMPA reduces surface expression of NR1 through regulation of GSK3beta. Neuroreport 20 (2009) 161-165
34. Obregon A.D., Schetinger M.R., Correa M.M., Morscch V.M., da Silva J.E., Martins M.A., et al. Effects per se of organic solvents in the cerebral acetylcholinesterase of rats. Neurochem Res 30 (2005) 379-384
35. Pearce N.J., Arch J.R.S., Clapham J.C., Coghlan M.P., Corcoran S.L., Lister C.A., et al. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3β on a muscle-specific promoter. Metabolism 53 (2004) 1322-1330
36. Pekary A.E., Carlson H.C., Yamada T., Sharp B., Walfish P.G., and Hershman J.M. Thyrotropin-releasing hormone levels decrease in hypothalamus of aging rats. Neurobiol Aging 5 (1984) 221-226
37. Pekary A.E., Faull K.F., Paulson M., Lloyd R.L., and Sattin A. TRH-like antidepressant peptide, pyroglutamyltyrosylprolineamide, occurs in rat brain. J Mass Spectrom 40 (2005) 1232-1236
38. Pekary A.E., Meyer N.V., Vaillant C., and Hershman J.M. Thyrotropin-releasing hormone and a homologous peptide in the male rat reproductive system. Biochem Biophys Res Commun 95 (1980) 993-1000
39. Pekary A.E., and Sattin A. Regulation of TRH and TRH-like peptides in rat brain by thyroid and steroid hormones. Peptides 22 (2001) 1161-1173
40. Pekary A.E., Sattin A., Blood J., and Furst S. TRH and TRH-like peptide expression in rat following episodic or continuous corticosterone. Psychoneuroendocrinology 33 (2008) 1183-1197
41. 2 (EEP) in rat brain. Peptides 20 (1999) 107-119
42. Pekary A.E., Sattin A., Meyerhoff J.L., and Chilingar M. Valproate modulates TRH receptor, TRH and TRH-like peptide levels in rat brain. Peptides 25 (2004) 647-658
43. Pekary A.E., Senanayake S., and Sattin A. Cocaine regulates TRH-related peptides in rat brain. Neurochem Int 41 (2002) 415-428
44. Pekary A.E., Stevens S.A., and Sattin A. Rapid modulation of TRH and TRH-like peptide levels in rat brain and peripheral tissues by corticosterone. Neurochem Int 48 (2006) 208-217
45. Pekary A.E., Stevens S.A., and Sattin A. Circadian rhythms of TRH-like peptide levels in rat brain. Brain Res 1125 (2006) 67-76
46. Pekary A.E., Stevens S.A., and Sattin A. Valproate and copper accelerate TRH-like peptide synthesis in male rat pancreas and reproductive tissues. Peptides 27 (2006) 2901-2911
47. Pekary A.E., Stevens S.A., and Sattin A. Lipopolysaccharide modulation of thyrotropin-releasing hormone (TRH) and TRH-like peptide levels in rat brain and endocrine organs. J Mol Neurosci 31 (2007) 245-259
48. Ring D.B., Johnson K.W., Henriksen E.J., Nuss J.M., Goff D., Kinnick T.R., et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52 (2003) 588-595
49. Sakoda H., Gotoh Y., Katagiri H., Kurokawa M., Ono H., Onishi Y., et al. Differing roles of Akt and serum-and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 278 (2003) 25802-25807
50. Sattin A. The role of TRH and related peptides in the mechanism of action of ECT. J ECT 15 (1999) 76-92
51. Sattin A., Pekary A.E., and Blood J. Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues. Neuroendocrinology 88 (2008) 135-146
52. Scalabrino G.A., Hogan N., O'Boyle K.M., Slator G.R., Gregg D.J., Fitchett C.M., et al. Discovery of a dual action first-in-class peptide that mimics and enhances CNS-mediated actions of thyrotropin-releasing hormone. Neuropharmacology 52 (2007) 1472-1481
53. Stenoien D.S., and Brady S.T. Immunochemical analysis of kinesin light chain function. Mol Biol Cell 8 (1997) 675-689
54. Takashima A. GSK-3 is essential in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 9 3 Suppl. (2006) 309-317
55. Tatebayashi Y., Haque N., Tung Y.C., Iqbal K., and Grundke-Iqbal I. Role of tau phosphorylation by glycogen synthase kinase 3β in the regulation of organelle transport. J Cell Sci 117 (2004) 1653-1663
56. Tsai M.-Y., Morfini G., Szebenyi G., and Brady S.T. Modulation of kinesin-vesicle interactions by Hsc70: implications for regulation of fast axonal transport. Mol Biol Cell 11 (2000) 2161-2173
57. 11C]AR-A014418): A radiolabelled glycogen synthase kinase-3β specific inhibitor for PET studies. Bioorg Med Chem Lett 15 (2005) 5270-5273
58. Wagman A.S., Johnson K.W., and Bussiere D.E. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes. Curr Pharm Des 10 (2004) 1105-1137
59. Woodgett J.R. Physiological roles of GSK-3 potential as a therapeutic target for diabetes and other disorders. Curr Drug Targets Immune Endocr Metabol Disord 3 (2003) 281-290
60. Wyatt A.W., Hussain A., Amann K., Klingel K., Kandolf R., Artunc F., et al. DOCA-induced phosphorylation of glycogen synthase kinase 3beta. Cell Physiol Biochem 17 (2006) 137-144
61. Zeng H., Schimpf B.A., Rohde A.D., Pavlova M.N., Gragerov A., and Bergmann J.E. Thyrotropin-releasing hormone receptor 1-deficient mice display increased depression and anxiety-like behavior. Mol Endocrinol 21 (2007) 2795-2804
62. Zhou F.-Q., and Snider W.D. GSK-3β and microtubule assembly in axons. Science 308 (2005) 211-214
63. Zmijewski J.W., and Jope R.S. Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts. Aging Cell 3 (2004) 309-317